220 related articles for article (PubMed ID: 33174555)
1. Isolation of DNA aptamers targeting N-cadherin and high-efficiency capture of circulating tumor cells by using dual aptamers.
Gao T; Ding P; Li W; Wang Z; Lin Q; Pei R
Nanoscale; 2020 Nov; 12(44):22574-22585. PubMed ID: 33174555
[TBL] [Abstract][Full Text] [Related]
2. Selection of DNA aptamers against epithelial cell adhesion molecule for cancer cell imaging and circulating tumor cell capture.
Song Y; Zhu Z; An Y; Zhang W; Zhang H; Liu D; Yu C; Duan W; Yang CJ
Anal Chem; 2013 Apr; 85(8):4141-9. PubMed ID: 23480100
[TBL] [Abstract][Full Text] [Related]
3. A PLGA nanofiber microfluidic device for highly efficient isolation and release of different phenotypic circulating tumor cells based on dual aptamers.
Wu Z; Pan Y; Wang Z; Ding P; Gao T; Li Q; Hu M; Zhu W; Pei R
J Mater Chem B; 2021 Mar; 9(9):2212-2220. PubMed ID: 33616137
[TBL] [Abstract][Full Text] [Related]
4. Selection of Aptamers Against Vimentin for Isolation and Release of Circulating Tumor Cells Undergoing Epithelial Mesenchymal Transition.
Zheng Y; Zhang J; Huang M; Wang T; Qu X; Wu L; Song J; Wang W; Song Y; Yang C
Anal Chem; 2020 Apr; 92(7):5178-5184. PubMed ID: 32148021
[TBL] [Abstract][Full Text] [Related]
5. A platform for primary tumor origin identification of circulating tumor cells via antibody cocktail-based in vivo capture and specific aptamer-based multicolor fluorescence imaging strategy.
Jia M; Mao Y; Wu C; Wang S; Zhang H
Anal Chim Acta; 2019 Nov; 1082():136-145. PubMed ID: 31472702
[TBL] [Abstract][Full Text] [Related]
6. Dual-Multivalent-Aptamer-Conjugated Nanoprobes for Superefficient Discerning of Single Circulating Tumor Cells in a Microfluidic Chip with Inductively Coupled Plasma Mass Spectrometry Detection.
Zhang X; Wei X; Men X; Wu CX; Bai JJ; Li WT; Yang T; Chen ML; Wang JH
ACS Appl Mater Interfaces; 2021 Sep; 13(36):43668-43675. PubMed ID: 34473482
[TBL] [Abstract][Full Text] [Related]
7. Novel Peptide-Based Magnetic Nanoparticle for Mesenchymal Circulating Tumor Cells Detection.
Jia F; Wang Y; Fang Z; Dong J; Shi F; Zhang W; Wang Z; Hu Z
Anal Chem; 2021 Apr; 93(14):5670-5675. PubMed ID: 33788544
[TBL] [Abstract][Full Text] [Related]
8. Selection of DNA aptamer recognizing CD44 for high-efficiency capture of circulating tumor cells.
Gao T; Li W; Ma J; Chen Y; Wang Z; Sun N; Pei R
Talanta; 2023 Sep; 262():124728. PubMed ID: 37247446
[TBL] [Abstract][Full Text] [Related]
9. EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy.
Le Du F; Fujii T; Kida K; Davis DW; Park M; Liu DD; Wu W; Chavez-MacGregor M; Barcenas CH; Valero V; Tripathy D; Reuben JM; Ueno NT
PLoS One; 2020; 15(3):e0229903. PubMed ID: 32214335
[TBL] [Abstract][Full Text] [Related]
10. High-Efficiency Isolation and Rapid Identification of Heterogeneous Circulating Tumor Cells (CTCs) Using Dual-Antibody-Modified Fluorescent-Magnetic Nanoparticles.
Wang Z; Sun N; Liu H; Chen C; Ding P; Yue X; Zou H; Xing C; Pei R
ACS Appl Mater Interfaces; 2019 Oct; 11(43):39586-39593. PubMed ID: 31577122
[TBL] [Abstract][Full Text] [Related]
11. Aptamer-mediated DNA concatemer functionalized magnetic nanoparticles for reversible capture and release of circulating tumor cells.
Zhang YT; Dong M; Xu PP; Cai JH; Liu SH; Gao YB; Wang LB; Li J; Jiang H; Wang JD; Wang DS
Colloids Surf B Biointerfaces; 2022 Oct; 218():112733. PubMed ID: 35981473
[TBL] [Abstract][Full Text] [Related]
12. In vivo inhibition of circulating tumor cells by two apoptosis-promoting circular aptamers with enhanced specificity.
Dong H; Han L; Wang J; Xie J; Gao Y; Xie F; Jia L
J Control Release; 2018 Jun; 280():99-112. PubMed ID: 29746957
[TBL] [Abstract][Full Text] [Related]
13. Selection of Metastatic Breast Cancer Cell-Specific Aptamers for the Capture of CTCs with a Metastatic Phenotype by Cell-SELEX.
Li WM; Zhou LL; Zheng M; Fang J
Mol Ther Nucleic Acids; 2018 Sep; 12():707-717. PubMed ID: 30098503
[TBL] [Abstract][Full Text] [Related]
14. Improved ovarian cancer EMT-CTC isolation by immunomagnetic targeting of epithelial EpCAM and mesenchymal N-cadherin.
Po JW; Roohullah A; Lynch D; DeFazio A; Harrison M; Harnett PR; Kennedy C; de Souza P; Becker TM
J Circ Biomark; 2018; 7():1849454418782617. PubMed ID: 30013673
[TBL] [Abstract][Full Text] [Related]
15. Layer-by-layer fabrication of alginate/polyethyleneimine multilayer on magnetic interface with enhanced efficiency in immuno-capturing circulating tumor cells.
Xiao Y; Zhou Z; Zuo Y; Wu X; Liu Y; Li Y; Gao Y; Zhang X; Wang Y; Hu L; Li C
Anal Chim Acta; 2024 Jul; 1312():342778. PubMed ID: 38834257
[TBL] [Abstract][Full Text] [Related]
16. DNA Hydrogel with Aptamer-Toehold-Based Recognition, Cloaking, and Decloaking of Circulating Tumor Cells for Live Cell Analysis.
Song P; Ye D; Zuo X; Li J; Wang J; Liu H; Hwang MT; Chao J; Su S; Wang L; Shi J; Wang L; Huang W; Lal R; Fan C
Nano Lett; 2017 Sep; 17(9):5193-5198. PubMed ID: 28771008
[TBL] [Abstract][Full Text] [Related]
17. Aptamers Selected to Postoperative Lung Adenocarcinoma Detect Circulating Tumor Cells in Human Blood.
Zamay GS; Kolovskaya OS; Zamay TN; Glazyrin YE; Krat AV; Zubkova O; Spivak E; Wehbe M; Gargaun A; Muharemagic D; Komarova M; Grigorieva V; Savchenko A; Modestov AA; Berezovski MV; Zamay AS
Mol Ther; 2015 Sep; 23(9):1486-96. PubMed ID: 26061649
[TBL] [Abstract][Full Text] [Related]
18. Aptamer-Based Methods for Detection of Circulating Tumor Cells and Their Potential for Personalized Diagnostics.
Zamay AS; Zamay GS; Kolovskaya OS; Zamay TN; Berezovski MV
Adv Exp Med Biol; 2017; 994():67-81. PubMed ID: 28560668
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling of single circulating tumor cells in ovarian cancer - Establishment of a multi-marker gene panel.
Blassl C; Kuhlmann JD; Webers A; Wimberger P; Fehm T; Neubauer H
Mol Oncol; 2016 Aug; 10(7):1030-42. PubMed ID: 27157930
[TBL] [Abstract][Full Text] [Related]
20. EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.
Schneck H; Gierke B; Uppenkamp F; Behrens B; Niederacher D; Stoecklein NH; Templin MF; Pawlak M; Fehm T; Neubauer H;
PLoS One; 2015; 10(12):e0144535. PubMed ID: 26695635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
